Aldawaa 9M 2023 profit grows 10% to SAR 236.9 mln; Q3 at SAR 71.3 mln

Aldawaa 9M 2023 profit grows 10% to SAR 236.9 mln; Q3 at SAR 71.3 mln

31/10/2023 Argaam Exclusive

View other reports

Aldawaa Medical Services Co. (DMSCO) posted a 10% profit jump in the first nine months of 2023 to SAR 236.9 million, compared to SAR 215.9 million in the year-earlier period, thanks to an increase in sales, which led to an improvement in gross profit and operating profits.



Financials (M)

Item 9m 2022 9m 2023 Change‬
Revenues 3,913.94 4,283.28 9.4 %
Gross Income 1,485.91 1,581.53 6.4 %
Operating Income 243.95 346.88 42.2 %
Net Income 215.94 236.87 9.7 %
Average Shares 85.00 85.00 -
EPS (Riyals) 2.54 2.79 9.7 %

The company reported a 9.4% rise year-on-year (YoY) in the nine-month revenue. Gross profit grew by 6.4% YoY to SAR 1.58 billion.

 

Operating profit jumped 39% YoY to SAR 339 million in the current period, with a profit margin of 7.9% of net sales, compared to 6.2% in the corresponding period of 2022.

 

In Q3 2023, net profit climbed 48% to SAR 71.3 million from SAR 48.15 million in Q3 2022.

 

Revenue grew by 9.9% YoY. Gross profit increased by 7.4% YoY to SAR 520.9 million.



Current Quarter Comparison (M)

Compared With The
Item Q3 2022 Q3 2023 Change‬
Revenues 1,308.93 1,438.95 9.9 %
Gross Income 484.94 520.91 7.4 %
Operating Income 82.69 104.60 26.5 %
Net Income 48.15 71.28 48.0 %
Average Shares 85.00 85.00 -
EPS (Riyals) 0.57 0.84 48.0 %

Operating profit leapt 23.3% YoY to SAR 102 million in the current period, with a profit margin of 7.1% of net sales, compared to 6.3% in the corresponding period of 2022.

 

Aldawaa’s Q3 bottom line dropped 20.2% from SAR 89.33 million in Q2 2023, hurt by higher selling and distribution expenses on new openings. The company also reported higher promotional offers expenses to maintain the sales.

 

Shareholders’ equity, no minority interest, reached SAR 1.20 billion as of Sept. 30, 2023, up from SAR 1.02 billion a year earlier.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 1,176.38 - 446.33 - 91.48 -
Q2 2020 1,303.84 - 530.76 - 131.66 -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 1,209.72 2.8 % 451.96 1.3 % 74.35 (18.7 %)
Q2 2021 1,266.77 (2.8 %) 457.98 (13.7 %) 66.91 (49.2 %)
Q3 2021 1,259.56 - 451.39 - 50.81 -
Q4 2021 1,298.34 - 533.08 - 75.82 -
Q1 2022 1,294.82 7.0 % 494.18 9.3 % 70.71 (4.9 %)
Q2 2022 1,310.19 3.4 % 506.79 10.7 % 90.55 35.3 %
Q3 2022 1,308.93 3.9 % 484.94 7.4 % 82.69 62.7 %
Q4 2022 1,458.30 12.3 % 533.69 0.1 % 130.39 72.0 %
Q1 2023 1,407.59 8.7 % 534.98 8.3 % 116.00 64.0 %
Q2 2023 1,436.74 9.7 % 525.64 3.7 % 126.28 39.5 %
Q3 2023 1,438.95 9.9 % 520.91 7.4 % 104.60 26.5 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 23.11 - 0.29 (52.93) 76.04 0.95
Q2 2020 55.35 - 0.69 (61.91) 117.26 1.47
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 78.84 241.2 % 0.99 21.49 57.35 0.72
Q2 2021 52.94 (4.4 %) 0.62 5.84 47.10 0.55
Q3 2021 38.29 - 0.45 9.85 28.44 0.33
Q4 2021 69.08 - 0.81 26.24 42.84 0.50
Q1 2022 87.11 10.5 % 1.02 38.14 48.97 0.58
Q2 2022 80.67 52.4 % 0.95 14.47 66.21 0.78
Q3 2022 48.15 25.7 % 0.57 (1.08) 49.24 0.58
Q4 2022 89.51 29.6 % 1.05 7.74 81.77 0.96
Q1 2023 76.25 (12.5 %) 0.90 - 76.25 0.90
Q2 2023 89.33 10.7 % 1.05 - 89.33 1.05
Q3 2023 71.28 48.0 % 0.84 - 71.28 0.84

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 37.63 % 11.95 % 3.49 %
Q1 2022 37.83 % 12.05 % 3.27 %
Q2 2022 38.46 % 12.59 % 3.61 %
Q3 2022 38.74 % 13.20 % 3.98 %
Q4 2022 37.59 % 13.57 % 4.58 %
Q1 2023 37.56 % 13.96 % 4.99 %
Q2 2023 37.05 % 14.35 % 5.29 %
Q3 2023 36.84 % 14.47 % 5.55 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 79.85 - - -
Q2 2020 79.85 - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 79.85 - - 14.62
Q2 2021 85.00 - - 14.74
Q3 2021 85.00 - - 12.46
Q4 2021 85.00 2.81 2.07 11.64
Q1 2022 85.00 2.91 1.97 12.61
Q2 2022 85.00 3.24 2.19 12.78
Q3 2022 85.00 3.35 2.44 12.07
Q4 2022 85.00 3.59 2.90 12.88
Q1 2023 85.00 3.47 3.22 12.67
Q2 2023 85.00 3.57 3.49 14.74
Q3 2023 85.00 3.84 3.75 14.17

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 25.59 37.84 5.91
Q2 2022 20.70 30.54 5.24
Q3 2022 23.77 32.69 6.61
Q4 2022 20.01 24.83 5.58
Q1 2023 23.08 24.87 6.31
Q2 2023 27.61 28.23 6.68
Q3 2023 24.77 25.37 6.71

Business Segments (Million)

Compared With The
Period Retail Sales Wholesale Logistic Services
Q1 2021 1,169.76 39.96 -
Q2 2021 1,234.85 31.92 -
Q3 2021 1,224.38 35.18 -
Q4 2021 1,257.00 41.34 -
Q1 2022 1,260.57 34.25 -
Q2 2022 1,268.35 41.84 -
Q3 2022 1,261.85 47.08 -
Q4 2022 1,376.54 81.76 -
Q1 2023 1,341.18 66.41 -
Q2 2023 1,366.98 69.76 -
Q3 2023 1,352.17 86.77 -

Analysts Estimates (Million)

Item Q3 2023 (e) Q3 2023 (a) Change‬
Average 68.15 71.28 4.60 %

Estimates vs Actual (Million)

Item Q3 2023 (e) Q3 2023 (a) Change
SNB Capital 76.30 71.28 (6.6) %
Riyad Capital 60.00 71.28 18.8 %

Current
Market Cap (M Riyal) 6,808.50
Enterprise Value (EV) (M) 7,366.97
Shares Outstanding ((M)) 85.00
EPS ( Riyal) (TTM) 4.22
Book Value (BV) ( Riyal) 16.65
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 18.98
P/E (TTM) 18.98
Price/book 4.81
Return on Average Assets (%) (TTM) 7.5
Return on Average Equity (%) (TTM) 27.4

Share Price

Aldawaa Medical Services Co. (ALDAWAA)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.